SalafiaCMPezzuloJCLopez-ZenoJAMiniorVKPlacental pathologic features of preterm pre-eclampsiaAm J Obstet Gynecol199517341097–110510.1016/0002-9378(95)91333-5
2.
ShanklinDRSibaiBMUltrastructural aspects of preeclampsia I. Placental bed and uterine boundary vesselsAm J Obstet Gynecol19891613735–741
3.
MartinJNJrRinehartBKMayWLThe spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classificationAm J Obstet Gynecol19991806 Pt 11373–138410.1016/S0002-9378(99)70022-0
4.
CurtinWMWeinsteinLA Review of HELLP syndrome: State of the ArtJ Perinatol1999192138–14310.1038/sj.jp.7200165
5.
BaxterJKWeinsteinLHELLP syndrome: the state of the artObstet Gynecol Surv20045912838–84510.1097/01.ogx.0000146948.19308.c5
6.
WilsonWAGharaviAEKoikeTInternational consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshopArthritis Rheum19994271309–131110.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
7.
MiyakisSLockshinMDAtsumiTInternational consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)J Thromb Haemost200642295–30610.1111/j.1538-7836.2006.01753.x
8.
BranchDWSilverRMBlackwellJLReadingJCScottJROutcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experienceObstet Gynecol1992804614–620
9.
Le Thi ThuongDTieulieNCostedoatNThe HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 womenAnn Rheum Dis2005642273–27810.1136/ard.2003.019000
10.
HuongDLWechslerBBletryOA study of 75 pregnancies in patients with the antiphospholipid syndromeJ Rheumatol2001282025–2030
11.
BranchDWScottJRKochenourNKObstetric complications associated with the lupus anticoagulantN Engl J Med1985313211322–132610.1056/NEJM198511213132104
12.
RoteNSWalterALydenTWAntiphospholipid antibodies—lobsters or red herringsAm J Reprod Immunol199228131–37
13.
SammaritanoLRUpdate on the management of the pregnant patient with antiphospholipid antibodyCurr Rheumatol Rep200133213–22110.1007/s11926-001-0021-6
14.
ErkanDThe relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: review of the literature and management strategiesCurr Rheumatol Rep200245379–38610.1007/s11926-002-0081-2
15.
MagidMSKaplanCSammaritanoLRPlacental pathology in systemic lupus erythematosus: a prospective studyAm J Obstet Gynecol19981791226–23410.1016/S0002-9378(98)70277-7
16.
Van HornJTCravenCWardKHistologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid like syndromesPlacenta2004257642–64810.1016/j.placenta.2003.12.006
17.
Infante-RievardCDavidMGauthierRLupus anticoagulants, anticardiolipin antibodies and fetal lossN Engl J Med1991325151063–106610.1056/NEJM199110103251503
18.
RandJHWuXXAndreeHAPregnancy loss in the antiphospholipid–antibody syndrome—a possible thrombogenic mechanismN Engl J Med19973373154–16010.1056/NEJM199707173370303
19.
SimantovRLaSalaJLoSKActivation of cultured vascular endothelium by antiphospholipid antibodiesJ Clin Invest1995962211–221910.1172/JCI118276
20.
PierangeliSSColden-StanfieldMLiuXAntiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivoCirculation199999151997–2002
21.
BranchDWDudleyDJMitchellMDImmunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BABL/c mice: a model for autoimmune fetal lossAm J Obstet Gynecol19901631 Pt 1210–216
22.
HolersVMGirardiGGuthridgeGMComplement C3 activation is required for antiphospholipid antibody-induced fetal lossJ Exp Med20021952211–22010.1084/jem.200116116
23.
GirardiGRedechaPBermanJComplement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndromeJ Clin Invest2004112111644–165410.1172/JCI200318817
24.
PierangeliSSGirardiGVega-OstertagMRequirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophiliaArthritis Rheum20055272120–212410.1002/art.21157
25.
GirardiGRedechaPSalmonJEHeparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activationNat Med200410111222–122610.1038/nm1121
26.
DereksonRHDe GrootPGKaterLNieuwenhuisHKPatients with Antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatmentAnn Rheum Dis199352689–692
27.
SibaiBMDiagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet countObstet Gynecol20041035 Pt 1981–991
